Pembrolizumab in Elderly Patients With Advanced Lung Cancer

Clinical trial NCT03293680 · COMPLETED

Trial details

NCT number: NCT03293680
Sponsor: Spanish Lung Cancer Group
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Non Small Cell Lung Cancer

Start date: 2017-01-15
Primary completion: 2023-04-28
Enrollment: 83

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.